Stevanato Group S.p.A. (STVN) stock
STVNNYSESurgical & Medical Instruments & Apparatus
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 4, 2026Score 8/30
$15.36+0.11 (+0.72%)
Close on Nov 18, 2026Market cap $4.65BP/E 27.3Yield –
Stevanato Group S.p.A. r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was €25.44M, down 19.7% from the year before. The highest annual figure on record is €35.67M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €25.44M | -19.7% |
| FY2024 | Dec 31, 2024 | €31.67M | -11.2% |
| FY2023 | Dec 31, 2023 | €35.67M | +3.7% |
| FY2022 | Dec 31, 2022 | €34.39M | +16.1% |
| FY2021 | Dec 31, 2021 | €29.62M | +70.3% |
| FY2020 | Dec 31, 2020 | €17.39M | +122.2% |
| FY2019 | Dec 31, 2019 | €7.83M | – |
See a number that looks wrong?